With its G20 presidency, India has a unique opportunity to remove trade barriers for its pharmaceutical products in many countries, the domestic drug industry has told the Indian government.
Asking the government to negotiate to remove trade barriers, industry stalwarts have urged the government to lead in the development of a G20 prequalification system or an alternative pathway to market access for drugs that would be similar to the WFP qualification system.
In the G20, major economies representing more than 80% of the world's GDP and 75% of its trade convene at an international level.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze